Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
148.4 USD | -0.47% | +1.78% | +358.59% |
24/06 | US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit | RE |
24/06 | J&J: 50M pupils helped through 'Sight for Kids' program | CF |
Chart calendar Johnson & Johnson
Upcoming events on Johnson & Johnson
Past events on Johnson & Johnson
12/06/2024 11:30 pm | Goldman Sachs Global Healthcare Conference |
29/05/2024 11:00 pm | Bernstein Strategic Decisions Conference |
20/05/2024 | Détachement de |
15/05/2024 08:30 pm | RBC Capital Markets Global Healthcare Conference |
15/05/2024 02:10 am | BofA Securities Health Care Conference |
03/05/2024 | American Urological Association Meeting - Abstract No: PD48-02 |
01/05/2024 05:30 pm | Business Update Call |
25/04/2024 07:30 pm | Annual General Meeting |
17/04/2024 11:15 pm | American Academy of Neurology Meeting - Poster No : 11-019 |
17/04/2024 07:30 pm | American Academy of Neurology Meeting - Poster No : 11-015 |
16/04/2024 06:00 pm | Q1 2024 Earnings Call |
16/04/2024 03:50 pm | Q1 2024 Earnings Release |
15/04/2024 11:15 pm | American Academy of Neurology Meeting - Poster No : 11-011 |
15/04/2024 11:15 pm | American Academy of Neurology Meeting - Poster No : 14-008 |
15/04/2024 11:15 pm | American Academy of Neurology Meeting - Poster No : 11-019 |
15/04/2024 11:15 pm | American Academy of Neurology Meeting - Poster No : 11-006 |
08/04/2024 | American College of Cardiology Scientific Meeting - Abstract #90604 |
06/04/2024 | American College of Cardiology Scientific Meeting - Abstract No:406-14 |
06/04/2024 | American College of Cardiology Scientific Meeting - Abstract No:1511-205 |
06/04/2024 | American College of Cardiology Scientific Meeting - Abstract No:1293-203 |
Past dividends on Johnson & Johnson
20/05/2024 | Quarterly 1.24 USD |
16/02/2024 | Quarterly 1.19 USD |
20/11/2023 | Quarterly 1.19 USD |
25/08/2023 | Quarterly 1.19 USD |
22/05/2023 | Quarterly 1.19 USD |
17/02/2023 | Quarterly 1.13 USD |
21/11/2022 | Quarterly 1.13 USD |
22/08/2022 | Quarterly 1.13 USD |
23/05/2022 | Quarterly 1.13 USD |
18/02/2022 | Quarterly 1.06 USD |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 82 059 82 193 -0.16% | 82 584 81 721 1.06% | 93 775 94 304 -0.56% | 94 943 95 017 -0.08% | 85 159 84 764 0.47% | 88 746 |
EBITDA Million USD | Released Forecast Spread | 27 979 28 680 -2.45% | 27 145 27 951 -2.88% | 36 634 33 066 10.79% | 32 630 32 564 0.2% | 30 414 31 998 -4.95% | 32 019 |
EBIT Million USD | Released Forecast Spread | 25 593 25 615 -0.09% | 24 574 24 992 -1.67% | 29 244 30 088 -2.8% | 29 965 29 608 1.21% | 27 460 27 881 -1.51% | 28 866 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 17 328 19 476 -11.03% | 16 497 19 030 -13.31% | 22 776 24 759 -8.01% | 21 725 25 756 -15.65% | 15 062 20 454 -26.36% | 26 262 |
Net income Million USD | Released Forecast Spread | 15 119 16 943 -10.76% | 14 714 15 924 -7.6% | 20 878 22 542 -7.38% | 17 941 20 668 -13.19% | 35 153 19 696 78.48% | 0,00 |
EPS USD | Released Forecast Spread | 5,63 6,47 -13.03% | 5,51 6,10 -9.72% | 7,81 8,42 -7.29% | 6,73 7,95 -15.29% | 13,7 8,44 62.56% | 0,00 |
Announcement Date | 22/01/20 | 26/01/21 | 25/01/22 | 24/01/23 | 23/01/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 23 426 23 618 -0.81% | 24 020 23 825 0.82% | 23 791 23 433 1.53% | 23 706 23 901 -0.82% | 24 746 23 599 4.86% | 25 530 24 668 3.49% | 21 351 21 049 1.43% | 21 395 21 017 1.8% | 21 383 21 386 -0.01% | 22 295 | 22 440 | 22 632 | 22 137 | 23 167 |
EBITDA Million USD | Released Forecast Spread | 9 305 8 964 3.8% | 9 011 8 659 4.07% | 9 299 8 682 7.11% | 7 804 7 485 4.26% | 8 880 8 484 4.66% | 8 912 8 671 2.78% | 8 071 7 683 5.04% | 6 333 6 788 -6.7% | 7 973 7 747 2.92% | 8 129 | 8 107 | 7 828 | 8 343 | 8 443 |
EBIT Million USD | Released Forecast Spread | 7 536 7 874 -4.29% | 7 267 7 763 -6.39% | 7 614 7 858 -3.1% | 7 093 6 702 5.83% | 8 204 7 411 10.7% | 8 189 7 753 5.62% | 7 374 6 967 5.83% | 5 638 6 015 -6.27% | 7 236 7 203 0.46% | 7 437 | 7 408 | 7 100 | 7 573 | 7 735 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 5 862 7 060 -16.97% | 5 840 6 856 -14.82% | 5 822 6 646 -12.4% | 4 201 6 020 -30.22% | -737 6 708 -110.99% | 6 762 7 242 -6.63% | 5 217 7 202 -27.56% | 4 826 5 043 -4.3% | 6 440 6 329 1.75% | 6 903 | 6 552 | 6 031 | ||
Net income Million USD | Released Forecast Spread | 4 458 5 921 -24.71% | 3 520 4 621 -23.82% | -68,0 5 573 -101.22% | 5 144 5 866 -12.3% | 26 028 | 4 049 3 880 4.34% | 5 354 5 293 1.15% | |||||||
EPS USD | Released Forecast Spread | 1,93 2,17 -11.06% | 1,80 2,19 -17.68% | 1,68 2,08 -19.36% | 1,33 1,87 -29% | -0,03 2,10 -101.43% | 1,96 1,89 3.45% | 10,2 2,17 370.51% | 1,67 1,68 -0.81% | 2,20 2,21 -0.57% | |||||
Announcement Date | 19/04/22 | 19/07/22 | 18/10/22 | 24/01/23 | 18/04/23 | 20/07/23 | 17/10/23 | 23/01/24 | 16/04/24 | - | - | - | - | - |
Past sector events for Johnson & Johnson
21/06/2024 08:58 pm | DEVA HOLDING: Q1 2024 Earnings Release |
14/06/2024 02:51 am | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
11/06/2024 11:00 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
07/06/2024 04:03 pm | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
07/06/2024 02:47 pm | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
30/05/2024 05:38 pm | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
30/05/2024 04:30 pm | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
30/05/2024 11:54 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
29/05/2024 05:30 pm | FDC LIMITED: Q4 2024 Earnings Release |
29/05/2024 02:56 pm | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- JNJ Stock
- 0R34 Stock
- Calendar Johnson & Johnson